Changes in Orbital Macrovascular and Intraocular Microvascular Blood Flow After Orbital Decompression Surgery in Patients With Thyroid Eye Disease
BOD-VASC
Evaluation of the Effect of Bilateral Balanced Orbital Decompression on Orbital, Retinal, and Choroidal Macro and Microvascular Blood Flow Parameters in Thyroid-Associated Orbitopathy
1 other identifier
interventional
15
1 country
1
Brief Summary
This study aims to evaluate the effects of balanced orbital decompression surgery in patients with inactive thyroid-associated orbitopathy. The study examines how the surgery influences blood flow in the orbit and microcirculation in the retina and choroid over time. Clinical findings, imaging results, and vascular changes before and after surgery will be analyzed to better understand the anatomical and functional outcomes of the procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 4, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 25, 2024
CompletedFirst Submitted
Initial submission to the registry
January 29, 2026
CompletedFirst Posted
Study publicly available on registry
February 6, 2026
CompletedFebruary 6, 2026
February 1, 2026
1.1 years
January 29, 2026
February 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in ophthalmic artery flow velocities
Change in peak systolic velocity and end-diastolic velocity of the ophthalmic artery, measured in cm/s, assessed by color Doppler ultrasonography before and after surgery.
Baseline and postoperative follow-up visits at 1, 3, and 6 months
Change in central retinal artery flow velocities
Change in peak systolic velocity and end-diastolic velocity of the central retinal artery, measured in cm/s, assessed by color Doppler ultrasonography before and after surgery.
Baseline and postoperative follow-up visits at 1, 3, and 6 months
Change in superior ophthalmic vein diameter
Change in superior ophthalmic vein diameter, measured in millimeters (mm), assessed by magnetic resonance imaging before and after surgery.
Baseline and postoperative follow-up visits at 1, 3, and 6 months
Secondary Outcomes (4)
Change in superficial capillary plexus vessel density
Baseline and postoperative follow-up visits at 1, 3, and 6 months
Change in deep capillary plexus vessel density
Baseline and postoperative follow-up visits at 1, 3, and 6 months
Change in choriocapillaris vessel density
Baseline and postoperative follow-up visits at 1, 3, and 6 months
Change in choroidal vascularity index
Baseline and postoperative follow-up visits at 1, 3, and 6 months
Study Arms (1)
Balanced Orbital Decompression Surgery
EXPERIMENTALParticipants in this arm undergo balanced orbital decompression surgery performed for inactive thyroid-associated orbitopathy, with preoperative and postoperative clinical and vascular assessments.
Interventions
Balanced orbital decompression is performed under general anesthesia using a combined medial and lateral orbital wall approach with orbital fat removal, aiming to reduce orbital pressure and improve orbital and ocular circulation in patients with inactive thyroid-associated orbitopathy.
Eligibility Criteria
You may qualify if:
- Adults aged 18 years or older
- Diagnosis of inactive thyroid-associated orbitopathy
- Presence of moderate-to-severe proptosis with indication for surgical orbital decompression
- Planned to undergo balanced orbital decompression surgery
- Ability to provide written informed consent
- Adequate image quality for OCTA and Doppler ultrasonography assessments
You may not qualify if:
- Active phase thyroid-associated orbitopathy
- Thyroid dysfunction or systemic condition contraindicating general anesthesia
- Proptosis due to causes other than TAO
- History of orbital radiotherapy
- Previous orbital or intraocular surgery
- Presence of retinal or choroidal pathology affecting vascular measurements
- History of systemic vasculitis or other vascular diseases
- Diabetes mellitus or systemic hypertension
- Use of systemic immunosuppressive therapy
- Age under 18 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Marmara University School of Medicine, Department of Ophthalmology
Istanbul, Pendik, 34899, Turkey (Türkiye)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ophthalmologist, Department of Ophthalmology, Marmara University School of Medicine
Study Record Dates
First Submitted
January 29, 2026
First Posted
February 6, 2026
Study Start
April 4, 2023
Primary Completion
April 30, 2024
Study Completion
May 25, 2024
Last Updated
February 6, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share